Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: LANTHEUS MI CANADA INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02333236 | LANTHEUS MI CANADA INC | ABLAVAR | Human | Yes | Ethical | 1 | GADOFOSVESET TRISODIUM | 244 MG / ML |
Marketed | 02328003 | LANTHEUS MI CANADA INC | CARDIOLITE | Radiopharmaceutical | Yes | Schedule C | 1 | TETRAKIS [CU(MIBI)4]BF4 | 1 MG / VIAL |
Marketed | 02243173 | LANTHEUS MI CANADA INC | DEFINITY | Human | Yes | Prescription | 1 | PERFLUTREN | 150 MCL / ML |
Cancelled Post Market | 02327759 | LANTHEUS MI CANADA INC | GALLIUM | Radiopharmaceutical | No | Schedule C | 1 | GALLIUM CITRATE GA 67 | 74 MBq / ML |
Cancelled Pre Market | Not Applicable | LANTHEUS MI CANADA INC | MIRALUMA | Radiopharmaceutical | No | Schedule C | 1 | TETRAKIS [CU(MIBI)4]BF4 | 1 MG / VIAL |
Marketed | 02327848 | LANTHEUS MI CANADA INC | NEUROLITE | Radiopharmaceutical | No | Schedule C | 1 | BICISATE DIHYDROCHLORIDE | 0.9 MG / VIAL |
Marketed | 02328550 | LANTHEUS MI CANADA INC | TECHNELITE | Radiopharmaceutical | Yes | Schedule C | 1 | TECHNETIUM TC 99M | 740 GBQ / GEN |
Cancelled Post Market | 02327945 | LANTHEUS MI CANADA INC | THALLIUM | Radiopharmaceutical | No | Schedule C | 1 | THALLIUM CHLORIDE(TI 201) | 2 MCI / ML |
Cancelled Pre Market | Not Applicable | LANTHEUS MI CANADA INC | THALLIUM | Radiopharmaceutical | No | Schedule C | 1 | THALLIUM CHLORIDE(TI 201) | 1 MCI / ML |
Cancelled Pre Market | Not Applicable | LANTHEUS MI CANADA INC | XENON | Radiopharmaceutical | No | Schedule C | 1 | XENON 133 XE | 10 MCI / VIAL |
Cancelled Pre Market | Not Applicable | LANTHEUS MI CANADA INC | XENON | Radiopharmaceutical | No | Schedule C | 1 | XENON 133 XE | 20 MCI / VIAL |
Application information
Related information
Contact us
Version 4.0.3